Shalby Ltd. · NSE:SHALBY
Shalby — Q4 FY2025 Earnings Presentation
48 slides from Shalby's earnings presentation, May 30, 2025
Slide 1: Cover letter to stock exchanges
Shalby/SE/2025‐26/12 May 30, 2025 The Listing Department Corporate Service Department National Stock Exchange of India Ltd BSE Limited Mumbai 400 051. Mumbai 400 001. Scrip Code : SHALBY Scrip Code: 540797 Through : https://neaps.nseindia.com/NEWLISTINGCORP/ Through : http://listing.bseindia.com Sub
Slide 2: Investors Presentation Q4 & FY2025
Investors Presentation Q4 & FY2025
Slide 3: Disclaimer
DISCLAIMER This presentation and its contents are confidential and are not for release, publication or distribution, in whole or in part, directly or indirectly, in or into or from the United States of America, Canada, Australia, Japan or any jurisdiction where such distribution is unlawful. This pr
Slide 4: Agenda
AGENDA 01 SHALBY GROUP QUARTERLY AND ANNUAL PERFORMANCE 02 HOSPITAL BUSINESS QUARTERLY AND ANNUAL PERFORMANCE 03 IMPLANT BUSINESS QUARTERLY AND ANNUAL PERFORMANCE 04 FRANCHISE BUSINESS QUARTERLY AND ANNUAL PERFORMANCE 05 SHALBY ACADEMY QUARTERLY AND ANNUAL PERFORMANCE 06 HOMECARE BUSINESS QUARTERLY
Slide 5: Financials Snapshot Q4 FY25
Financials Snapshot Q4 FY25 Consolidated Revenue at ₹ 2,702 mn in Q4 FY25 vs ₹ 2,492 mn in Q4 FY24 Consolidated EBITDA at ₹ 262 mn in Q4 FY25 vs ₹ 439 mn in Q4 FY24 Consolidated Consolidated PBT at ₹ (7) mn in Q4 FY25 vs ₹ 218 mn in Q4 FY24 Financial Highlights Consolidated Net debt stood at ₹ 2,790
Slide 6: Consolidated Performance Highlights – Q4 FY25
Consolidated Performance Highlights – Q4 FY25 Revenue (INR MN) EBITDA1 & Margin (INR MN) 439 2,811 393 2,702 262 2,492 17.6% 14.0% 9.7% Q4FY24 Q3FY25 Q4FY25 Q4FY24 Q3FY25 Q4FY25 Up 8.4% Down 40.4% 5 1. EBITDA includes other income
Slide 7: Consolidated Performance Highlights – FY25
Consolidated Performance Highlights – FY25 Revenue (INR MN) EBITDA1 & Margin (INR MN) 11,146 1,965 1,602 9,532 20.6% 14.4% FY24 FY25 FY24 FY25 Up 16.9% Down 18.5% 6 1. EBITDA includes other income
Slide 8: Consolidated P/L & B/S – Q4 FY25
Consolidated P/L & B/S – Q4 FY25 Profit & Loss (INR Mn) Balance Sheet (INR Mn) Q4 Q3 Q4 Q-o-Q Y-o-Y Gross 4267 Particulars (Rs. Millions) Borrowings FY25 FY25 FY24 Growth Growth Revenue 2702 2811 2492 (3.9%) 8.4% Cash & Cash 1477 Equivalents EBITDA2 262 393 439 (33.5%) (40.4%) Net Cash/(Debt) (2790)
Slide 9: Financial Trends – Shalby Limited (Consolidated)
Financial Trends – Shalby Limited (Consolidated) Revenue (In INR Cr) EBITDA (In INR Cr) & Margin (%) 1115 953 196 827 159 160 711 132 504 99 95 440 20% 22% 19% 19% 21% 14% FY20 FY21 FY22 FY23 FY24 FY25 FY20 FY21 FY22 FY23 FY24 FY25 ROCE (%) 14% 13% 11% 8% 8% 8% FY20 FY21 FY22 FY23 FY24 FY25
Slide 10: Diversification in Revenue Mix
High Growth Business Verticals Healthcare Conglomerate Multi-Specialty Franchise Implant 11 Hospitals across western, northern 4 Hospital network USA based Knee & Hip and central India Manufacturing facility Synergistic Sustainable Business Model • Headroom to grow further with • An Asset light fran
Slide 11: A Legend and Visionary Doctorpreneur behind Shalby
A Legend and Visionary Doctorpreneur behind Shalby Dr Vikram I. Shah, the Founder of Shalby Ltd, is a world-renowned Joint Replacement Surgeon who innovated “Zero Technique” that revolutionized Joint Replacement Surgery. A visionary entrepreneur, he transformed Shalby from a 6 bedded hospital in 199
Slide 12: Hospital Business Performance
HOSPITAL BUSINESS PERFORMANCE 11
Slide 13: Hospital Business Highlights Q4 FY25
Hospital Business Highlights Q4 FY25 Global leader in Joint replacements with more than 1,75,000 surgeries Surgery Count and YoY Growth Operational Performance3 Q4 Q4 YoY Particulars FY25 FY24 Growth Arthroplasty Orthopaedic In-Patient1 (Nos.) 21,202 21,313 (0.5%) 3140+ 8.7% 1100+ 23.4% Out Patient
Slide 14: Standalone Business Highlights – Q4 FY25
Standalone Business Highlights – Q4 FY25 Financial Performance Revenue (INR Mn) EBITDA1 & Margin (INR Mn) 2,269 488 426 380 2,142 2,107 20.2% 21.5% 17.7% Q4FY24 Q3FY25 Q4FY25 Q4FY24 Q3FY25 Q4FY25 Up 1.7% Down 10.9% PBT & Margin (INR Mn) 358 325 257 15.4% 15.8% 12.0% Q4FY24 Q3FY25 Q4FY25 Down 21.0% 1
Slide 15: Standalone Business Highlights – FY25
Standalone Business Highlights – FY25 Financial Performance Revenue (INR Mn) EBITDA1 & Margin (INR Mn) 8,991 1,983 1,857 8,504 23.3% 20.7% FY24 FY25 FY24 FY25 Down Up 5.7% 6.4% PBT & Margin (INR Mn) 1,583 1,358 18.6% 15.1% FY24 FY25 14 Down 14.2% 1. EBITDA includes other income
Slide 16: Standalone Business P&L and B/S – Q4 FY25
Standalone Business P&L and B/S – Q4 FY25 Profit & Loss (INR Mn) Total Revenue to EBITDA Q4 Q3 Q4 QoQ YoY Other expenses Particulars (Rs Mn) FY25 FY25 FY24 Growth Growth 9.3% 8.3% 12.1% 11.3% Employee Benefit 8.5% 8.6% Expenses Total Revenue 2142 2269 2107 (5.6%) 1.7% Other Operative 25.2% 28.3% Exp
Slide 17: Shalby Sanar Q4 FY25 Highlights
Shalby Sanar Q4’FY25 Highlights IP Count Total 19200+ ARPOB 1050+ Employees Patients ₹84,647 Expertise in 320+ Total 58% Served in Liver, Revenue of revenue Doctors & FY24-25 OP Count Kidney, Consultant ₹228 Mn. in generated Total Bed ALOS 3.88 3690+ Blood & 50+ Q4’FY25 vs from Capacity 130 Bone 150
Slide 18: Hospital Business Highlights: Specialty Revenue Mix
Hospital Business Highlights Specialty Revenue Mix Q4 FY2024 Q4 FY2025 General Others Surgery, Others Surgery, Surgery, 5% 7% General 9% Arthroplasty, Surgery, 6% Arthroplasty, 38% 36% Nephrology, 6% Nephrology, 5% Neurology, 6% Neurology, 6% Orthopaedic, 8% Orthopaedic, 8% Critical Care & Critical
Slide 19: Hospital Business Highlights: Payor Mix
Hospital Business Highlights Payor Mix Q4 FY20241 Q4 FY20251 Government, 22% Government, 23% Self Pay, 37% Self Pay, 36% TPA/Insurance, TPA/Insurance, 41% 41% Notes: 18 1. .Q4’FY25 numbers includes PK Healthcare performance.
Slide 20: Financial Trends – Standalone Business
Financial Trends – Standalone Business 1 Revenue (In INR Cr) EBITDA (In INR Cr) & Margin (%) 900 850 198 727 186 660 162 143 501 428 99 96 20% 22% 22% 22% 23% 21% FY20 FY21 FY22 FY23 FY24 FY25 FY20 FY21 FY22 FY23 FY24 FY25 PAT (In INR Cr) & Margin (%) ROCE (%) 104 18% 16% 81 84 14% 14% 70 8% 8% 43 2
Slide 21: Operational Trends – Hospital Business
Operational Trends – Hospital Business 1,2 Bed Capacity Operational Beds Occupied Beds 2297 1415 633 659 1390 2267 1260 563 570 1235 1164 1164 448 428 2137 2112 2012 2012 FY20 FY21 FY22 FY23 FY24 FY25 FY20 FY21 FY22 FY23 FY24 FY25 FY20 FY21 FY22 FY23 FY24 FY25 Total Surgeries Count ARPOB (in INR) AL
Slide 22: Homecare Business Highlights FY24-25
Homecare Business Highlights FY24-25 FY24-25 Highlights Patients Served (Nos) Patients Served 30,044 in FY25 v/s 29,645 patients in FY24, up by 1.3% YoY 30,044 29,645 Revenue booked Rs.152.91 mn during FY25 v/s Rs.145.57 mn during FY24, grew by 5.0% YoY FY24 FY25 Physio, Diagnostics and Pharmacy are
Slide 23: Clinical Update And Research Across Units during Q4 FY25
Clinical Update And Research Across Units during Q4 FY25 ❖ Our commitment towards augmenting Shalby’s medical program has made notable strides in advancing our growth initiative from single-specialty to multi-specialty by various brand awareness campaign , through digital platform and other various
Slide 24: Key Focus Areas For Future In Hospital business
Key Focus Areas For Future In Hospital business Global Leader in Joint Replacement with diversification in other specialties • Continue to maintain global leadership in joint replacements • Ongoing diversification with Cardiac Science, Oncology, Neuro-science, Critical Care, General Medicine and Tra
Slide 25: Franchise Business
SHALBY ORTHOPEDICS CENTRE OF EXCELLENCE** FRANCHISE BUSINESS Build Health & Wealth » 24
Slide 26: Leveraging Expertise Through Franchise Asset Light Model
Leveraging Expertise Through Franchise Asset Light Model Franchise model will leverage Shalby expertise and enable to penetrate faster across pan-India Business models SOCE Performance in Q4 FY25 Franchise Owned – Shalby Operated (FOSO) Revenue (in ₹ mn) FOSO FOSM Total Q4’FY25 21.9 7.6 29.5 1. The
Slide 27: Shalby Academy
Q SHALBY ACADEMY OO SHALBY ACADEMY AUnit of SHALBY LiMMITED) 26
Slide 28: Shalby Academy
Shalby Academy Q4 FY25 highlights Students Enrolled (In Nos) 1. Around 595+ new students registered in Q4 FY24-25 in various disciplines like Physiotherapy, Nursing, Lab Technician Nutrition & and dietetics, Clinical, 2260 Paramedics, Hospital Management, and Pharmacy as part of their academic 2062
Slide 29: Implant Business
SF IMPLANT BUSINESS G SHALBY Global Technologies Pte. Ltd. 2 SAT ind ovine ives. Put. Ltd
Slide 30: Shalby MedTech Limited (Consolidated)
Shalby MedTech Limited (Consolidated) OPERATING REVENUE (in ₹mn) OPERATING REVENUE (in ₹mn) 296.02 930.59 253.58 556.51 124.32 Q4'FY24 Q3'FY25 Q4'FY25 FY24 FY25 Up 138.1% Up 67.2% Implant Components Sold Implant Components Sold 12,727 11,280 41,960 30,048 8,485 Q4'FY24 Q3'FY25 Q4'FY25 FY24 FY25 29 U
Slide 31: Shalby MedTech Limited (Standalone)
Shalby MedTech Limited (Standalone) OPERATING REVENUE (in ₹mn) Implant Components Purchased Implant Components Sold 118.32 112.01 13,017 6,899 12,632 12,594 6,529 44.87 2,606 Q4'FY24 Q3'FY25 Q4'FY25 Q4'FY24 Q3'FY25 Q4'FY25 Q4'FY24 Q3'FY25 Q4'FY25 Up 163.7% Down 0.3% Up 150.5% OPERATING REVENUE (in ₹
Slide 32: Shalby Advanced Technologies Inc. (Standalone)
Shalby Advanced Technologies Inc. (Standalone) OPERATING REVENUE (in ₹mn) Implant Components Sold 18,511 18,792 276.36 17,398 267.76 258.13 Q4'FY24 Q3'FY25 Q4'FY25 Q4'FY24 Q3'FY25 Q4'FY25 Up 7.1% Up 1.5% OPERATING REVENUE (in ₹mn) Implant Components Sold 1071.7 74,088 783.35 50,385 FY24 FY25 FY24 FY
Slide 33: Shalby Global Technologies Pte. Ltd. (Standalone)
Shalby Global Technologies Pte. Ltd. (Standalone) OPERATING REVENUE (in ₹mn) Components Sold 26.65 3543 7.04 3.43 189 160 Q4'FY24 Q3'FY25 Q4'FY25 Q4'FY24 Q3'FY25 Q4'FY25 Up 278.5% Up 1774.6% OPERATING REVENUE (in ₹mn) Implant Components Sold 63.72 4,931 14.3 681 FY24 FY25 FY24 FY25 Up 345.5% Up 624.
Slide 34: Core Strategic Pillar
Core Strategic Pillar ▪ Recruitment, retention & Portfolio & ▪ Continual training of Innovation training of sales and employees, HCPs and corporate teams Channel Partners ▪ Strong employee ▪ Solid Partner Relationship engagement, involvement and Supply People Customer ▪ Achieve industry-best Chain ❖
Slide 35: Implant Business Roadmap
Implant Business Roadmap Shalby Advanced Technologies plans to become a Global player in a phased manner Existing Phase 1 Phase 2 Phase 3 Market Latin America Middle East Countries East Africa North America • Argentina • UAE • Kenya • Columbia • Saudi Arabia • Ethiopia Japan South-East and North • O
Slide 36: About Shalby
ABOUT SHALBY 35
Slide 37: Shalby At A Glance
Shalby At A Glance OPD clinics Presence 15 60 23 Orthopedic Implant Hospitals1 Domestic International2 Manufacturing in USA 30 Strength 2,300+ 4,600+ 1,150+ Years of Legacy Bed Capacity Total Employees3 Doctors4 Team Clinical Excellence #1 30+ ~3.4 million+ 175,000+ Global Ranking in Specialties Pat
Slide 38: 30 Years of ELITE Legacy
30 Years of ELITE Legacy Integrity Highest standards of transparency accountability, and corporate governance Learning Team-Work Laser sharp focus on A patient-centric focused upgrading the skills of team with a great blend of our team and building experience, diversity, fresh people capability thin
Slide 39: Our Journey & Expansion Plan
Our Journey & Expansion Plan • Jaipur Shalby, Jaipur (237 beds) • Naroda Shalby, Ahmedabad (267 beds) Vijay Shalby, Ahmedabad • Vapi Shalby, Vapi (146 beds) • • Surat Shalby, Surat (243 beds) • Lucknow SOCE, 40 beds 27 beds • Krishna Shalby, Ahmedabad (220 • Zynova1 Shalby, Mumbai (100 beds) • Gwali
Slide 40: Hospitals Portfolio
Hospitals Portfolio Multispecialty Units (Owned and Operate) SG Shalby Vapi Shalby Indore Shalby Jaipur Shalby Krishna Shalby Mohali Shalby Naroda Shalby Jabalpur Shalby Surat Shalby Sanar Shalby 39
Slide 41: Franchise Hospital Portfolio
Franchise Hospital Portfolio Shalby Orthopedics Centre of Excellence (SOCE) Vijay Shalby Lucknow Shalby Multispecialty Zynova Shalby (Mumbai) (Shalby Operated) (Shalby Operated) Rajkot Shalby Gwalior Shalby (Shalby Managed) (Shalby Operated) (Shalby Managed) 40
Slide 42: Biggest Healthcare Corporate Group in Western and Central India
Biggest Healthcare Corporate Group in Western and Central India Domestic Presence…... PUNJAB ▪ Mohali – 145 beds Uttar Pradesh ▪ Lucknow – 40 beds DELHI ▪ Gurugram – 130 beds RAJASTHAN ▪ Jaipur – 237 beds GUJARAT ▪ Ahmedabad o SG – 201 beds o Krishna – 220 beds o Naroda – 267 beds Gujarat Rajkot – 3
Slide 43: Shalby Tissue Bank
SHALBY TISSUE BANK Preserving Tissues, Transforming Lives Available grafts A pioneering initiative by Shalby Hospitals •Cortico-cancellous chips (Freeze dried, irradiated) dedicated to advancing medical care through the •Cortico-cancellous chips (Frozen, irradiated) banking of high-quality allograft
Slide 44: Shalby Limited Shareholding Pattern (as on 31st March 2025)
Shalby Limited Shareholding Pattern (as on 31st March,25) Employee Benefit Trust 0.69% Public 20.32% DIIs 0.18% FIIs 4.54% Promoters 74.27% Promoters FIIs DIIs Public Employee Benefit Trust 43
Slide 45: Sustainability Initiatives
Sustainability Initiatives ESG Mindset “We at Shalby are embracing sustainability to drive new values to our business” Community Connect 480+ Healthcare Camps Trainings Healthcare Awareness Programs Workplace Wellness 10900+ Life impacted 5,750+ and 11,200+ Man Hours Clinical and Non-Clinical traini
Slide 46: Shalby Awards and Accolades
Shalby Awards and Accolades Best Hospital Shalby Mohali – Economic Times Award for Hospital Dr. Jasmeet Singh Consultant Diabetes- TIMES Healthcare leaders - Service Pioneer Healthcare centre in Tricity Chain of the Year West to Shalby Multi Pioneer in medical care. Excellence in Comprehensive Cance
Slide 47: Experienced Board Of Directors
Experienced Board Of Directors Dr. Ashok Bhatia Mr. Tej Malhotra Ms. Sujana Shah Independent Independent Independent Director Director Director Dr. Ashok Bhatia, a senior pharma professional has Mr. Malhotra boasts four decades of international and Mrs. Sujana Shah, a practicing Chartered Accountant
Slide 48: Thank You
Thank You For further information, please contact: Jigar Todi Investors Relation & Corporate Strategist +91 9512049871 ircs3.corp@shalby.org SHALBY LIMITED I Regd Off: Opp. Karnavati Club, S.G. Road, Ahmedabad – 380015, Gujarat, India. Phone: 079 4020 3000 Fax: +91 79 4020 3109 | Website: www.shalby